Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced that CEO, David Elsley, will present a company overview at the Cantor Fitzgerald 2023 Global Healthcare Conference on September 26, 2023, at 4:55 p.m. ET. The presentation will focus on Cardiol's research and clinical development of therapies for heart disease, specifically anti-inflammatory and anti-fibrotic treatments. The presentation can be viewed via live video webcast at www.wsw.com/webcast/cantor19/crdl/2077845.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com